By expenditures
| Name | Title | Type |
|---|---|---|
| Lindsey Fish | Principal | Auditee |
| Narcissus Rankin | Director of Business & Finance | Auditee |
| Hope Wheeler | Principal | Auditee |
| Anthony Cervini | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 356007 | 2024 | 2025-05-12 | Sikich CPA LLC | $33.68M |
| 299406 | 2023 | 2024-03-28 | Sikich LLP | $25.52M |
| 54627 | 2022 | 2023-03-20 | Cliftonlarsonallen LLP | $18.79M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 54627 | 2022 | 2023-03-20 | 635804 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635803 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635802 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635801 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635800 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635799 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635798 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635797 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635796 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 635795 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59362 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59361 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59360 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59359 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59358 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59357 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59356 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59355 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59354 | 2022-004 | Significant Deficiency | - | I |
| 54627 | 2022 | 2023-03-20 | 59353 | 2022-004 | Significant Deficiency | - | I |